Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr210 Inhibitors

Olr210 inhibitors represent a specific chemical class that targets the Olr210 protein, a member of the olfactory receptor family, which is known to play a role in signal transduction mechanisms associated with olfaction. These inhibitors are designed to modulate the activity of the Olr210 receptor by binding to its active site or allosteric regions, thereby influencing the receptor's conformational dynamics. The olfactory receptors, including Olr210, are G-protein-coupled receptors (GPCRs) that initiate a cascade of intracellular events upon binding to specific ligands. This interaction is typically characterized by conformational changes in the receptor, leading to the activation or inhibition of downstream signaling pathways. Olr210 inhibitors, by their design, disrupt these molecular interactions, which can be crucial for understanding the basic biological processes governed by this receptor.

The development and study of Olr210 inhibitors are essential in the context of molecular biology and biochemistry, as they provide insights into the structural and functional aspects of olfactory receptors. These compounds are valuable tools for probing the signaling mechanisms of the Olr210 receptor, enabling researchers to dissect the receptor's role in cellular communication and sensory perception. By modulating the receptor's activity, Olr210 inhibitors help elucidate the specificity and selectivity of olfactory signal transduction, contributing to a broader understanding of GPCR function in various physiological processes. Additionally, the exploration of these inhibitors may reveal new aspects of receptor-ligand interactions, which are fundamental to the field of structural biology and receptor chemistry.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Allopurinol

315-30-0sc-207272
25 g
$131.00
(0)

Inhibits xanthine oxidase, potentially affecting purine metabolism and related to Olr210.

Carvedilol

72956-09-3sc-200157
sc-200157A
sc-200157B
sc-200157C
sc-200157D
100 mg
1 g
10 g
25 g
100 g
$124.00
$240.00
$530.00
$999.00
$1530.00
2
(1)

Non-selective beta-blocker, can modulate cardiovascular signaling pathways influencing Olr210.

Diltiazem

42399-41-7sc-204726
sc-204726A
1 g
5 g
$209.00
$464.00
4
(1)

Calcium channel blocker, potentially affecting cardiac and smooth muscle function, related to Olr210.

Fluconazole

86386-73-4sc-205698
sc-205698A
500 mg
1 g
$54.00
$84.00
14
(1)

Antifungal, inhibits fungal cytochrome P450, potentially affecting pathways linked to Olr210.

Hydrochlorothiazide

58-93-5sc-207738
sc-207738A
sc-207738B
sc-207738C
sc-207738D
5 g
25 g
50 g
100 g
250 g
$55.00
$240.00
$333.00
$562.00
$988.00
(0)

Thiazide diuretic, can influence electrolyte balance, potentially impacting Olr210.

Ketoconazole

65277-42-1sc-200496
sc-200496A
50 mg
500 mg
$63.00
$265.00
21
(1)

Antifungal, inhibits cytochrome P450 enzymes, potentially impacting pathways related to Olr210.

Metformin

657-24-9sc-507370
10 mg
$79.00
2
(0)

Antidiabetic, can influence glucose metabolism, potentially affecting Olr210.

Pioglitazone

111025-46-8sc-202289
sc-202289A
1 mg
5 mg
$55.00
$125.00
13
(1)

Thiazolidinedione, affects insulin sensitivity, potentially influencing pathways linked to Olr210.

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

Beta-blocker, may modulate cardiovascular and nervous system pathways affecting Olr210.

Simvastatin

79902-63-9sc-200829
sc-200829A
sc-200829B
sc-200829C
50 mg
250 mg
1 g
5 g
$31.00
$89.00
$135.00
$443.00
13
(1)

Statin, inhibits HMG-CoA reductase, potentially affecting cholesterol synthesis and Olr210.